A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous cd34+ cell administration in patients with refractory angina: Design of the renew study
Thomas J. Povsic*, Candice Junge, Adel Nada, Richard A. Schatz, Robert A. Harrington, Charles J Davidson, F. David Fortuin, Dean J. Kereiakes, Farrell O. Mendelsohn, Warren Sherman, Gary L. Schaer, Christopher J. White, Duncan Stewart, Kenneth Story, Douglas W. Losordo, Timothy D. Henry
Dive into the research topics of 'A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous cd34+ cell administration in patients with refractory angina: Design of the renew study'. Together they form a unique fingerprint.